Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Clinical trial NCT01440569 · COMPLETED

Trial details

NCT number: NCT01440569
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome HIV Infections

Start date: 2011-09-01
Primary completion: 2012-08-01
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.